| Q52614656 | A Postgenomic Perspective on Molecular Cytogenetics |
| Q35026482 | A phenolic ester from Aglaia loheri leaves reveals cytotoxicity towards sensitive and multidrug-resistant cancer cells. |
| Q46832664 | Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia. |
| Q37187510 | Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia |
| Q56722375 | Acute lymphoblastic leukaemia |
| Q58481753 | Acute lymphoblastic leukaemia |
| Q24602387 | Acute lymphoblastic leukaemia |
| Q58481759 | Acute lymphoblastic leukemia |
| Q36752634 | Advances in the Biology of Acute Lymphoblastic Leukemia—From Genomics to the Clinic |
| Q26996537 | Advances in the Genetics of High-Risk Childhood B-Progenitor Acute Lymphoblastic Leukemia and Juvenile Myelomonocytic Leukemia: Implications for Therapy |
| Q38009099 | Advances in the molecular pathobiology of B-lymphoblastic leukemia |
| Q57783666 | American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders |
| Q33397024 | Array CGH in human leukemia: from somatics to genetics |
| Q89777282 | BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia |
| Q34165735 | CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia |
| Q36190123 | CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients |
| Q34325522 | CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia |
| Q38264921 | Cancer cytogenetics: methodology revisited |
| Q37920890 | Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma |
| Q37398079 | Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma |
| Q28756307 | Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally |
| Q46491885 | Chronic phase of ETV6-ABL1 positive CML responds to imatinib |
| Q33615910 | Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries |
| Q36954396 | Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray |
| Q34700651 | Copy Number Alterations and Methylation in Ewing's Sarcoma |
| Q33788643 | Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies |
| Q57291791 | Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease |
| Q37676290 | Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia |
| Q84713544 | Cytogenetics and molecular genetics of acute lymphoblastic leukemia |
| Q58481814 | Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia |
| Q84888123 | DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 |
| Q35545539 | Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A |
| Q37172988 | Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia |
| Q35356484 | Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. |
| Q37523893 | Diagnostic microarrays in hematologic oncology: applications of high- and low-density arrays |
| Q38321218 | Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category |
| Q33409795 | Differentiation therapy of leukemia: 3 decades of development |
| Q37388676 | Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization |
| Q33954847 | Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. |
| Q43152436 | Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype |
| Q34894425 | Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells |
| Q34411660 | Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia |
| Q41071566 | Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray |
| Q36359067 | Genetic technologies in cancer investigation - applications in aggresive lymphoid malignancies |
| Q35922398 | Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome |
| Q34139304 | Genome-Wide Mapping Of Copy Number Variations using SNP Arrays |
| Q57195431 | Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia |
| Q62719029 | Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays |
| Q37180251 | Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas |
| Q37401075 | Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. |
| Q82452891 | Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway |
| Q38223490 | Genomic characterization of acute leukemias |
| Q37359118 | Genomic characterization of childhood acute lymphoblastic leukemia |
| Q26829976 | Genomic profiling of B-progenitor acute lymphoblastic leukemia |
| Q34095608 | Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia |
| Q37782546 | Genomic profiling of high-risk acute lymphoblastic leukemia. |
| Q38381463 | Genomics in acute lymphoblastic leukaemia: insights and treatment implications |
| Q33712187 | Global genomic characterization of acute lymphoblastic leukemia |
| Q37785241 | Heritability of Hematologic Malignancies: From Pedigrees to Genomics |
| Q37109353 | Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations |
| Q59529320 | High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome |
| Q37470385 | High hyperdiploid childhood acute lymphoblastic leukemia |
| Q34358106 | IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia |
| Q36977450 | IKZF1 deletion is associated with a poor outcome in pediatric B‐cell precursor acute lymphoblastic leukemia in Japan |
| Q39730823 | IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan |
| Q27851563 | IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. |
| Q51566016 | Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array |
| Q41697696 | Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. |
| Q38337056 | Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies |
| Q37849259 | Improving outcomes for high-risk ALL: translating new discoveries into clinical care |
| Q30842603 | Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study |
| Q33370596 | Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks |
| Q58861769 | Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 proto |
| Q35932148 | KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia |
| Q36638675 | Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease |
| Q33417186 | Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy |
| Q54586063 | Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO) |
| Q40202514 | Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma |
| Q36290242 | Molecular genetics of B-precursor acute lymphoblastic leukemia |
| Q24657303 | Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia |
| Q47370037 | Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia. |
| Q54627237 | New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice |
| Q26749177 | New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia |
| Q92816227 | Next-Generation Sequencing in Acute Lymphoblastic Leukemia |
| Q39178745 | Next‐generation‐sequencing‐based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia |
| Q35783433 | Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis |
| Q38407773 | Oligo-based aCGH analysis reveals cryptic unbalanced der(6)t(X;6) in pediatric t(12;21)-positive acute lymphoblastic leukemia |
| Q39928776 | Oncogenic mutations of ALK kinase in neuroblastoma |
| Q50580724 | PAX5 alterations in genetically unclassified childhood Precursor B-cell acute lymphoblastic leukaemia |
| Q60170364 | PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 |
| Q51416496 | Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols |
| Q52888757 | Patterns and frequencies of acquired and constitutional uniparental isodisomies in pediatric and adult B-cell precursor acute lymphoblastic leukemia |
| Q38956273 | Pediatric T-cell acute lymphoblastic leukemia |
| Q57518106 | Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia: a collaborative retrospective study of the Tokyo Children's Cancer Study Group and Japan Association of Childhood Leukaemia Study |
| Q44133432 | Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia |
| Q27851831 | Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia |
| Q91997647 | SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain |
| Q38947537 | SNP Array in Hematopoietic Neoplasms: A Review |
| Q33517413 | SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations |
| Q36580010 | Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico. |
| Q33736439 | Segmentation of genomic and transcriptomic microarrays data reveals major correlation between DNA copy number aberrations and gene-loci expression |
| Q38350723 | Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells |
| Q37979954 | Single-Nucleotide Polymorphism Array Karyotyping in Clinical Practice: Where, When, and How? |
| Q34109454 | Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results |
| Q85640301 | Submicroscopic genomic imbalances in burkitt lymphomas/leukemias: Association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis |
| Q36352535 | Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia |
| Q34235906 | The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia |
| Q37995811 | The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia |
| Q46393939 | The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. |
| Q35135027 | The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias |
| Q43087329 | Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia |
| Q37143660 | Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. |
| Q36964314 | Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer |
| Q35467835 | Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance |
| Q36835203 | Whole genome scanning as a cytogenetic tool in hematologic malignancies |